Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
Abstract
Psoriasis is a multifactorial disease in which genetic, environmental and epigenetic factors regulating gene expression play a key role. In the “genomic era”, genome-wide association studies together with target genotyping platforms performed in different ethnic populations have found more than 50 genetic susceptible markers associated with the risk of psoriasis which have been identified so far. Up till now, the strongest association with the risk of the disease has been proved for HLA-C*06 gene. The majority of other psoriasis risk SNPs are situated near the genes encoding molecules involved in adaptive and innate immunity, and skin barrier function. Many contemporary studies indicate that the epigenetic changes: histone modification, promoter methylations, long non-coding and micro-RNA hyperexpression are considered as factors contributing to psoriasis pathogenesis as they regulate abnormal keratinocyte differentiation and proliferation, aberrant keratinocytes - inflammatory cells communication, neoangiogenesis and chronic inflammation. The circulating miRNAs detected in the blood may become specific markers in the diagnosis, prognosis and response to the treatment of the disease. The inhibition of expression in selected miRNAs may be a new promising therapy option for patients with psoriasis.
Citations
-
3 2
CrossRef
-
0
Web of Science
-
3 1
Scopus
Authors (25)
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.5114/ada.2020.96243
- License
- open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Postępy Dermatologii i Alergologii
no. 37,
pages 283 - 298,
ISSN: 1642-395X - Language:
- English
- Publication year:
- 2020
- Bibliographic description:
- Nedoszytko B., Szczerkowska-Dobosz A., Stawczyk-Macieja M., Owczarczyk-Saczonek A., Reich A., Bartosińska J., Batycka-Baran A., Czajkowski R., Dobrucki I., Dobrucki L., Górecka-Sokołowska M., Janaszak-Jasiecka A., Kalinowski L., Krasowska D., Purzycka-Bohdan D., Radulska A., Reszka E., Samotij D., Sobalska-Kwapis M., Słominski A., Strapagiel D., Szczęch J., Żmijewski M., Nowicki R.: Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis// Postępy Dermatologii i Alergologii -Vol. 37,iss. 3 (2020), s.283-298
- DOI:
- Digital Object Identifier (open in new tab) 10.5114/ada.2020.96243
- Verified by:
- Gdańsk University of Technology
seen 123 times
Recommended for you
Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
- A. Owczarczyk-Saczonek,
- D. Purzycka-Bohdan,
- B. Nedoszytko
- + 22 authors
Genetic and Epigenetic Aspects of Atopic Dermatitis
- B. Nedoszytko,
- E. Reszka,
- D. Gutowska-Owsiak
- + 13 authors
Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
- A. Radulska,
- I. Pelikant-Malecka,
- K. Jendernalik
- + 2 authors